LDL susceptibility to copper-induced oxidation after administration of a single dose of free or esterified beta-cryptoxanthin

Ann Nutr Metab. 2004;48(3):163-8. doi: 10.1159/000078380. Epub 2004 May 6.

Abstract

Background: The oxidative modification of LDL is believed to be an initial step in atherosclerosis. Thus, antioxidative substances such as carotenoids may have a role in the prevention of coronary heart disease. We examined the susceptibility of LDL to Cu2+ oxidation in young adults before and after a single dose of beta-cryptoxanthin.

Methods: 1.3 mg of beta-cryptoxanthin was administered to 12 apparently healthy young volunteers. Six of the volunteers received esters, the other six free beta-cryptoxanthin. The plasma concentration of beta-cryptoxanthin and the susceptibility of LDL to copper-induced oxidation ex vivo in terms of the duration of lag time were measured before and 12 h after beta-cryptoxanthin ingestion.

Results: A single dose of beta-cryptoxanthin significantly increased the mean plasma beta-cryptoxanthin concentration and the mean cholesterol adjusted beta-cryptoxanthin concentration by 117 and 133%, respectively. No effect on the length of lag time was assessed. However, in LDL isolated from plasma 12 h after beta-cryptoxanthin administration the lengths of lag time correlated significantly with the plasma beta-cryptoxanthin concentration and with the cholesterol adjusted beta-cryptoxanthin levels. The lag time did not differ significantly between volunteers who received esters and those who received the same dosage as free beta-cryptoxanthin. At both measuring points, smokers, male volunteers and women using oral contraceptives tended to exhibit lower beta-cryptoxanthin concentrations and lower cholesterol adjusted beta-cryptoxanthin concentrations as well as increased LDL oxidizability compared to nonsmokers and women not using oral contraceptives.

Conclusion: A single dose of beta-cryptoxanthin does not enhance the duration of LDL lag time ex vivo in healthy young subjects.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Arteriosclerosis / etiology
  • Arteriosclerosis / metabolism
  • Contraceptive Agents, Female / adverse effects
  • Contraceptive Agents, Female / metabolism
  • Copper / metabolism*
  • Cryptoxanthins
  • Esterification
  • Female
  • Humans
  • Lipoproteins, LDL / drug effects*
  • Lipoproteins, LDL / metabolism*
  • Male
  • Oxidation-Reduction
  • Smoking / adverse effects
  • Smoking / metabolism
  • Time Factors
  • Xanthophylls
  • beta Carotene / administration & dosage*
  • beta Carotene / analogs & derivatives*
  • beta Carotene / blood*
  • beta Carotene / pharmacology

Substances

  • Contraceptive Agents, Female
  • Cryptoxanthins
  • Lipoproteins, LDL
  • Xanthophylls
  • beta Carotene
  • Copper